Affiliation: Moorfields Eye Hospital and UCL Institute of Ophthalmology and National Institute of Health Research Biomedical Research Centre, London, United Kingdom.
Country: United Kingdom
Areas of Interest: Developing new therapies, particularly for preventing scarring and for regeneration, Developed surgical techniques (Moorfields Safer Surgery System) which have improved the safety and outcomes of antimetabolite assisted trabeculectomy and developed new anti-scarring regimens based on laboratory research, which led to international clinical trials. Currently involved in developing new anti-scarring drugs and delivery systems, as well as drainage devices, and has proposed the 10-10-10 challenge for glaucoma: an intraocular pressure of 10 mmHg for 10 years, done in 10 minutes.
Leadership Position: Director, UK National Institute for Health Research Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK; Director, Research & Development, Moorfields Eye Hospital, London, UK; Programme Director Eyes & Vision, UCL Partners, London, UK. Past President of ARVO.